These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Nortriptyline capacity-limited metabolism: a case report. Browne JL; Perry PJ; Taylor JW; Sieleni BA; Kronfol Z J Clin Psychopharmacol; 1984 Dec; 4(6):322-5. PubMed ID: 6511999 [TBL] [Abstract][Full Text] [Related]
25. Efficacy and feasibility of high dose tricyclic antidepressant treatment in elderly delusional depressives. Brown RP; Kocsis JH; Glick ID; Dhar AK J Clin Psychopharmacol; 1984 Dec; 4(6):311-5. PubMed ID: 6511997 [TBL] [Abstract][Full Text] [Related]
26. Nortriptyline pharmacokinetics and plasma levels: implications for clinical practice. Rubin EH; Biggs JT; Preskorn SH J Clin Psychiatry; 1985 Oct; 46(10):418-24. PubMed ID: 3900052 [TBL] [Abstract][Full Text] [Related]
27. Plasma concentrations of tricyclic antidepressants in clinical practice. Hollister LE J Clin Psychiatry; 1982 Feb; 43(2):66-9. PubMed ID: 7056706 [TBL] [Abstract][Full Text] [Related]
28. Plasma level monitoring of antidepressants: theoretical basis and clinical application. Gram LF; Kragh-Sørensen P; Kristensen CB; Møller M; Pedersen OL; Thayssen P Adv Biochem Psychopharmacol; 1984; 39():399-411. PubMed ID: 6380231 [TBL] [Abstract][Full Text] [Related]
29. Effect of tricyclic antidepressants on individual symptoms. Welner A; Welner Z; Robins E J Clin Psychiatry; 1980 Sep; 41(9):306-9. PubMed ID: 7410324 [TBL] [Abstract][Full Text] [Related]
30. Plasma monitoring of tricyclic antidepressants: defining the therapeutic range for imipramine in depressed children. Preskorn SH; Weller E; Hughes C; Weller R Clin Neuropharmacol; 1986; 9 Suppl 4():265-7. PubMed ID: 3552217 [No Abstract] [Full Text] [Related]
31. Extremely rapid hydroxylation of debrisoquine: a case report with implication for treatment with nortriptyline and other tricyclic antidepressants. Bertilsson L; Aberg-Wistedt A; Gustafsson LL; Nordin C Ther Drug Monit; 1985; 7(4):478-80. PubMed ID: 4082245 [No Abstract] [Full Text] [Related]
32. Using tricyclic antidepressants in the elderly. McCue RE Clin Geriatr Med; 1992 May; 8(2):323-34. PubMed ID: 1600482 [TBL] [Abstract][Full Text] [Related]
34. Tricyclic antidepressants--blood level measurements and clinical outcome: an APA Task Force report. Task Force on the Use of Laboratory Tests in Psychiatry. Am J Psychiatry; 1985 Feb; 142(2):155-62. PubMed ID: 3881999 [TBL] [Abstract][Full Text] [Related]
35. The contribution of pharmacokinetics to the best use of benzodiazepines and antidepressants. Gram LF Encephale; 1982; 8(2):291-8. PubMed ID: 6125380 [TBL] [Abstract][Full Text] [Related]
36. Inadequate dosing and pharmacokinetic variability as confounding factors in assessment of efficacy of antidepressants. Gram LF Clin Neuropharmacol; 1990; 13 Suppl 1():S35-44. PubMed ID: 2199035 [TBL] [Abstract][Full Text] [Related]
37. Recognition of depressive syndromes, tricyclics, and the second generation antidepressants. Tollefson G; Tuason VB Minn Med; 1984 Jun; 67(6):345-50. PubMed ID: 6147748 [No Abstract] [Full Text] [Related]
38. Specific tricyclic antidepressant binding sites in rat brain. Raisman R; Briley M; Langer SZ Nature; 1979 Sep; 281(5727):148-50. PubMed ID: 471061 [TBL] [Abstract][Full Text] [Related]
40. A survey of psychiatrists' practices related to the use of tricyclic antidepressants. Goldberg SC; Tilley DH; Friedel RO; Hamer RM; Ban TA Hosp Community Psychiatry; 1986 Dec; 37(12):1247-51. PubMed ID: 3804226 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]